For the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2, for example, 68,962 variants are reported as VUS and only 6,258 as benign or pathogenic (https://brcaexchange.org/; November 2022)1,4. This evidence concerns the gene BRCA2 and ovarian carcinoma.